Skip Navigation


Rheumatology Advance Access originally published online on May 18, 2004
Rheumatology 2004 43(8):973-979; doi:10.1093/rheumatology/keh224
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary data
Right arrow Note
Right arrow An addendum has been published
Right arrow All Versions of this Article:
43/8/973    most recent
keh224v2
keh224v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Barnes, M. G.
Right arrow Articles by Thompson, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barnes, M. G.
Right arrow Articles by Thompson, S. D.
Related Collections
Right arrow Juvenile Idiopathic Arthritis
Right arrow Spondylarthropathies
Right arrow Genetics of Paediatric Rheumatic Disease
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology Vol. 43 No. 8 © British Society for Rheumatology 2004; all rights reserved


Paper

Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic ELR+ chemokine genes relate to course of arthritis

M. G. Barnes, B. J. Aronow1, L. K. Luyrink, M. B. Moroldo, P. Pavlidis2, M. H. Passo, A. A. Grom, R. Hirsch3, E. H. Giannini, R. A. Colbert, D. N. Glass and S. D. Thompson

William S. Rowe Division of Rheumatology and 1 Division of Pediatric Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, 2 Genome Center and Department of Biomedical Informatics, Columbia University, New York, NY 10032 and 3 Division of Rheumatology, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, USA.

Correspondence to: S. D. Thompson, Division of Rheumatology, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA. E-mail: susan.thompson{at}cchmc.org

Objective. To evaluate the ability of microarray-based methods to identify genes with disease-specific expression patterns in peripheral blood mononuclear cells (PBMC) and synovial fluid mononuclear cells (SFMC) of juvenile arthritis patients and healthy controls.

Methods. Microarray data (Affymetrix U95Av2) from 26 PBMC and 20 SFMC samples collected from patients with active disease (classified by course according to ACR criteria) were analysed for expression patterns that correlated with disease characteristics. For comparison, PBMC gene expression profiles were obtained from 15 healthy controls. Real-time PCR was used for confirmation of gene expression differences.

Results. Statistical analysis of gene expression patterns in PBMC identified 378 probe sets corresponding to 342 unique genes with differing expression levels between polyarticular course patients and controls (t test, P<0.0001). The genes represented by these probe sets were enriched for functions related to regulation of immune cell functions, receptor signalling as well as protein metabolism and degradation. Included in these probe sets were a group of CXCL chemokines with functions related to angiogenesis. Further analysis showed that, whereas angiogenic CXCL (ELR+) gene expression was elevated in polyarticular PBMC, expression of angiostatic CXCL (ELR) chemokines was lower in polyarticular SFMC compared with corresponding pauciarticular samples (t test, P<0.05).

Conclusions. This pilot study demonstrates that juvenile arthritis patients exhibit complex patterns of gene expression in PBMC and SFMC. The presence of disease-correlated biologically relevant gene expression patterns suggests that the power of this approach will allow better understanding of disease mechanisms, identify distinct clinical phenotypes in disease subtypes, and suggest new therapeutic approaches.

KEY WORDS: Human, Juvenile, Rheumatoid arthritis, Chemokines, Inflammation, Polyarticular course, JAK/STAT


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.